IVF hartmann Holding AGXSWX:VBSN -0.79%74 EBITDA Margin % is 17.02% as of Dec. 2025, which is 10% above its 10-year median of 15.49. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.11 (Modestly Undervalued). Among 816 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 68.75% on this metric.
IVF hartmann Holding AG (XSWX:VBSN) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
IVF hartmann Holding AG EBITDA Margin % Related Terms
IVF hartmann Holding AG EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:VBSN vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (XSWX:VBSN) has a EBITDA Margin % of 17.02% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IVF hartmann Holding AG and its competitors. This is 10% above median its historical median of 15.49. Over the past decade, IVF hartmann Holding AG's EBITDA Margin % has ranged from 9.21 to 18.47. According to the industry distribution chart, IVF hartmann Holding AG ranks #255 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 31.2%.
Is IVF hartmann Holding AG's EBITDA Margin % too high?
IVF hartmann Holding AG's current EBITDA Margin % of 17.02% is 10% above median its 10-year median of 15.49. Over the past 10 years, this metric has ranged from a low of 9.21 to a high of 18.47. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. IVF hartmann Holding AG's value of 17.02% is 127.7% above this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #255 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #255 out of 816 companies for EBITDA Margin %. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median EBITDA Margin % is 7.48. IVF hartmann Holding AG's value of 17.02% is 127.7% above this benchmark. Historically, IVF hartmann Holding AG's own EBITDA Margin % has ranged from 9.21 to 18.47 over the past decade. While the company's 10-year median is 15.49 vs. the industry median of 7.48, IVF hartmann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current EBITDA Margin % of 17.02% is 127.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current EBITDA Margin % is 17.02%, which is 10% above median its own 10-year median of 15.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF143.11, compared to a current price of CHF126.00 — trading 12% below its estimated fair value. The current EBITDA Margin % is 17.02%, which is 10% above median its 10-year median of 15.49 and 127.7% above the Medical Devices & Instruments industry median of 7.48. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current EBITDA Margin % is 17.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF126.00 is trading 12% below its estimated GF Value™ of CHF143.11.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:VBSN:
EBITDA Margin %: 17.02% (10% above median its 10-year median of 15.49)
GF Value™: CHF143.11 vs. price of CHF126.00 (12% below fair value)
Industry Position: 127.7% above the Medical Devices & Instruments median (#255 of 816)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
